Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...
Hims & Hers' lower-priced injectable semaglutide promoted during the Super Bowl has led to some patients receiving the more ...
After the FDA removed semaglutide injection products from a shortage list, compounders like Hims have 60-90 days to stop ...
When the FDA declared an Ozempic and Wegovy shortage, business boomed for pharmacies making cheaper, off-brand versions of ...
A legal dispute over tirzepatide’s availability is reshaping diabetes and weight loss treatment access, raising concerns for ...
The Cleveland Clinic also warns against buying into the “nature’s Ozempic” hype but says the supplement could also aid in ...
Patients report that GLP-1 drugs like Ozempic and Mounjaro reduce “food noise,” the constant mental chatter about eating.
The "Hims and Hers" commercial railed against the weight loss industry and promoted the company's weight loss drug offerings as a less costly option compared to brand-name drugs. ABC News ...
Coverage complications are not unusual in the U.S. health care system. But the challenge is magnified for these obesity ...
U.S. involvement in WHO flu meetings, the UK's approval of Moderna's RSV vaccine, efforts against a measles outbreak in Texas ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback